Biocompatibility of Peritoneal Dialysis Fluids

Marichal J.F. , Faller B. , Brignon P. , Degoulet P. , Aime F. Peritonitis in continuous ambulatory peritoneal dialysis: a role for the dialysate? Nephron 1986; 42: 167–70.

Verger C. , Brunschvicg O. , Le Charpentier Y. , Lavergne A. Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis. Proc EDTA 1981; 18: 199–205.

Di Paolo N. , Sacchi G. , De Mia M. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986; 44: 204–11.

Dobbie J.W. , Zaki M.A. The ultrastructure of the parietal peritoneum in normal and uremic man and in patients on CAPD. In: Maher J.F. , and Winchester J.F. , eds. Frontiers in peritoneal dialysis. New York: Field, Rich and Associates Inc, New York City, 1986; 3–10.

Van Bronswijk H. , Verbrugh H.A. , Bos H.J. , Heezius ECJM , Oe P.L. , Van der Meulen J. , Verhoef J. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Peritoneal Dialysis Int 1989; 9: 197–202.

Liberek T. , Topley N. , Mistry C. In vitro biocompatibility of glucose polymer dialysis fluid. Submitted for publication.

Topley N. , Mackenzie R. , Petersen M.M. In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid. Nephrol Dial Transplant 1991; 6: 574–81.

Slater N.D. , Cope G.H. , Raftery A.T. Mesothelial hyperplasia in response to peritoneal dialysis fluid: a morpho-metric study in the rat. Nephron 1991; 58: 466–71.

Topley N. , Alobaidi H.M.M. , Davies M. , Coles G.A. , Williams J.D. , Lloyd D. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34: 404–11.

Goldstein C.S. , Bomalaski J.S. , Zurier R.B. , Neilson E.G. , Douglas S.D. Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Kidney Int 1984; 26: 733–40.

Jörres A. , Jörres D. , Topley N. Gahl GM, Mahiout A. Leukotriene release from peripheral and peritoneal leukocytes following exposure to solutions for peritoneal dialysis. Nephrol Dial Transplant 1991; 6: 495–501.

Rubin J. , Lin L.M. , Lewis R. , Cruse J. , Bower J.D. Host defense mechanisms in continuous ambulatory peritoneal dialysis. Clin Nephrol 1983; 20: 140–4.

Alobaidi H.M. , Coles G.A. , Davies M. , Lloyd G. Host defense in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function. Nephrol Dial Transplant 1986; 1: 16–21.

Gallimore B. , Gagnon R.F. , Stevenson M.M. Cytotoxicity of commercial peritoneal dialysis solutions towards peritoneal cells of chronically uremic mice. Nephron 1986; 43: 283–9.

Jörres A. , Jörres D. , Gahl G.M. Leukotriene B₄ and tumor necrosis factor release from leukocytes: effect of peritoneal dialysate. Nephron 1991; 58: 276–82.

McGregor S.J. , Brock J.H. , Briggs J.D. , Junor B.J.R. Bactericidal activity of peritoneal macrophages from continuous ambulatory dialysis patients. Nephrol Dial Transplant 1987; 2: 104–8.

Peterson P.K. , Lee D. , Suh H.J. Intracellular survival of Candida albicans in peritoneal macrophages from chronic peritoneal dialysis patients. Am J Kidney Dis 1986; 7: 146–52.

Verbrugh H.A. , Keane W.F. , Hoidal J.R. , Freiberg M.R. , Elliot G.R. , Peterson P.K. Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis 1983; 147: 1018–29.

Verbrugh H.A. , Keane W.F. , Conroy W.E. , Peterson P.K. Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluid. J Clin Microbiol 1984; 20: 199–203.

Duwe A.K. , Vas S.I. , Weatherhead J.W. Effect of the composition of peritoneal dialysis fluid on chemolumi-nescence, phagocytosis, and bactericidal activity in vitro. Infect Immun 1981; 33; 130–5.

Ing B.L. , Gupta D.K. , Nawab Z.M. , Zhou F-Q , Rahman M.A. , Daugirdas J.T. Suppression of neutrophil superoxide production by conventional peritoneal dialysis solutions. Int J Artif Organs 1988; 11: 351–4.

Mackenzie R.K. , Coles G.A. , Williams J.D. Eicosanoid synthesis in human peritoneal macrophages stimulated with S. epidermide. Kidney Int 1990; 37: 1316–24.

Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568–76.

Bray M.A. The pharmacology and pathophysiology of leukotriene B₄. Brit Med Bull 1983; 39: 249–54.

Beutler B. , Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med 1987; 311: 379–85.

Old L.J. Tumor necrosis factor (TNF). Science 1985; 230: 630–2.

Elias J.A. , Gustilo K. , Baeder W. , Freundlich B. Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J Immunol 1987; 138: 3812–6.

Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1–10.

Goldman M. , Vandenabeele P. , Moulart J. , Amraoui Z. , Abramowicz D. , Nortier J. , Vanherweghem J.L. , Fiers W. Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis. Nephron 1990; 56: 277–80.

Topley N. , Jörres A. , Schindler R. , Davies M. , Coles G. , Williams J.D. Peritoneal mesothelial cells synthesise interleukin-6 induced by interleukin-1 (IL-1/β) and tumour necrosis factor (TNFa). Submitted for publication.

Jörres A. , Richter D. , Hain H. , Gahl G. , Müller C. , Köttgen E. , Mahiout A. Cytokine release from peripheral and peritoneal phagocytes: effect of CAPD dialysate (Abstr.). Kidney Int 1990; 37: 329.

Jörres A. , Goldman M. , Abramowicz D. , Müller C. , Köttgen E. , Jörres D. , Gahl G.M. Interleukin-6 and tumor necrosis factor release from mononuclear leukocytes: inhibition by peritoneal dialysate. Excerpta Medica 1991 (in press).

Jörres A. , Mahiout A. , Steenweg L. Tumor necrosis factor (TNFa) release from mononuclear leukocytes: effect of solutions for peritoneal dialysis (Abstr.) Nephrol Dial Transplant 1990; 5: 718.